Agenda

View Meeting Video

Friday, January 20, 2023

CME/CNE-accredited Conference

7:30 AM - 3:45 PM EST

Virtually via AJI Media Livecast powered by Accelevents

7:30 am

Login to Virtual Conference - Visit Virtual Exhibit Hall

8:00 am  

Welcome and Introductions

Edward A. Stadtmauer, MD  |  Activity Director
Robert H. Vonderheide, MD, DPhil  |  Director, Abramson Cancer Center

8:10 am

KEYNOTE: Transplant and Cellular Therapy: What can you do in 35 years?

David. L. Porter, MD  |  Activity Co-Director

PANEL DISCUSSION

MODERATORS: Edward A. Stadtmauer, MD & Stephen J. Schuster, MD | Activity Co-Directors

8:40 am

PANEL:

Catherine E. Lai, MD, MPH  |  Activity Co-Director
Alison W. Loren, MD, MSCE  |  Activity Co-Director
David. L. Porter, MD  |  Activity Co-Director
Jakub Svoboda, MD  |  Activity Co-Director

NEW THERAPIES AND CURRENT PATIENT MANAGEMENT OF LYMPHOMAS

MODERATOR: Stephen J. Schuster, MD  |  Activity Co-Director

8:55 am

Novel Therapies in Follicular and Marginal Zone Lymphomas

9:10 am

Advances in CLL and Mantle Cell Lymphoma

9:25 am

Updates in Management of Hodgkin Lymphoma

Jakub Svoboda, MD  |  Activity Co-Director

9:40 am

Therapeutic Advances in T-Cell Lymphomas

9:55 am

Targeted Therapy of Aggressive B-Cell Lymphomas

10:10 am

Evolving Role of Immune Modulation Therapies Including CART and Bispecific Antibodies in Lymphoma Management

Panel Discussion

MODERATOR: Stephen J. Schuster, MD  |  Activity Co-Director

10:25 am

PANEL:

Stefan K. Barta MD, MS, MRCPCUK  |  Hematology Oncology
Jordan S. Carter, MD  |  Hematology Oncology
Elise A. Chong, MD  |  Hematology Oncology
Gamil S. Hanna, MD  |  Hematology Oncology
Mitchell E. Hughes, PharmD, BCOP  |  Oncology Pharmacy
Danielle Land, MSN, CRNP  |  Hematology Oncology
Daniel J. Landsburg, MD  |  Hematology Oncology
Sunita D. Nasta, MD, FACP  |  Hematology Oncology
John P. Plastaras, MD, PhD  |  Radiation Oncology
Jakub Svoboda, MD  |  Activity Co-Director

10:45 am

Break and Visit Exhibits

UPDATE ON PATIENT CARE TREATMENT STRATEGIES IN LEUKEMIA

Moderator: Keith W. Pratz, MD  |  Activity Co-Director

10:55 am

Emerging Treatment Options for AML/MDS

11:10 am

Update in Hereditary Myeloid Disorders

11:25 am

Update in CML and Myeloproliferative Disease

11:40 am

Immunotherapies of Acute Leukemias

Panel Discussion

MODERATORS: Keith W. Pratz, MD & Catherine E. Lai, MD, MPH  |  Activity Co-Directors

11:55 am

PANEL:

Alison Carulli, PharmD  |  Oncology Pharmacy
Elizabeth O. Hexner, MD, MSTR  |  Hematology Oncology
Ximena Jordan-Bruno, MD  |  Hematology Oncology
Lindsay M. Lee, MSN, CRNP  |  Hematology Oncology
Selina M. Luger, MD  |  Hematology Oncology
Alexander E. Perl, MD  | Hematology Oncology
John P. Plastaras, MD, PhD  |  Radiation Oncology
Sunil Saroha, MD  |  Hematology Oncology

12:15 pm

Break and Visit Exhibits

UPDATE IN BLOOD AND MARROW TRANSPLANTATION AND CELLULAR THERAPY

MODERATORS: David L. Porter, MD & Alison W. Loren, MD, MSCE  |  Activity Co-Directors

12:45 pm

CAR T Cells for Solid Tumors

1:00 pm

Improving Access to Allogenic Transplant By Assessing Frailty

1:15 pm

New Approaches to Preventing and Treating GVHD

Panel Discussion

MODERATORS: David L. Porter, MD & Alison W. Loren, MD, MSCE | Activity Co-Directors

1:30 pm

PANEL:

Noelle Frey, MD  |  Hematology Oncology
Craig Freyer, PharmD  |  Oncology Pharmacy
Nasheed M. Hossain, MD  |  Hematology Oncology
Shannon R. McCurdy, MD  |  Hematology Oncology
Linda Perry, PA-C  |  Hematology Oncology
John P. Plastaras, MD, PhD  |  Radiation Oncology

CONTROVERSIES AND UPDATE FOR PATIENT CARE IN MULTIPLE MYELOMA

Moderator: Edward A. Stadtmauer, MD  |  Activity Director

1:45 pm

Smoldering Myeloma and Myeloma Precursor States

2:10 pm

Initial Therapy for Multiple Myeloma Including Transplant

2:30 pm

Role of Immunotherapy for Myeloma

2:50 pm 

Experimental Therapies for Relapsed Myeloma

Panel Discussion

MODERATOR: Edward A. Stadtmauer, MD  |  Activity Director

3:10 pm

PANEL:

Adam D. Cohen, MD  |  Hematology Oncology
Alfred L. Garfall, MD  |  Hematology Oncology
Oxana Megherea, PharmD  |  Oncology Pharmacy
John P. Plastaras, MD, PhD  |  Radiation Oncology
Leah Power, MSN, CRNP   |  Hematology Oncology
Sandra P. Susanibar-Adaniya, MD  |  Hematology Oncology 
Dan T. Vogl, MD, MSCE  |  Hematology Oncology

3:45 PM

Adjourn